Novavax sees royalties, reduced expenses on COVID vaccines from Sanofi partnership
Novavax on Thursday posted a narrower fourth-quarter loss and said it expects its licensing deal with French drugmaker Sanofi ...
COVID-flu vaccine could provide broader immunity and lasting protection
Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both ...
Novavax Q4 Loss Narrower Than Expected, Sales Beat Estimates
NVAX reports encouraging fourth-quarter results. It completes the sale of its Czech Republic manufacturing unit to Novo ...
Health Experts Sound Alarm as FDA Cancels Key Vaccine Meeting
Rumors are spreading all over the place.’ Experts fear the cancellation signals a sidelining of science at federal health ...
Novavax Inc (NVAX) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Financial ...
Novavax Inc (NVAX) outlines its strategic focus on partnerships and pipeline expansion while navigating revenue fluctuations ...
Novavax Reports Smaller Q4 Loss, Shifts Focus From Commercializing COVID-19 Vaccine To Maximize Value
Novavax reported Q4 sales of $88.31 million, beating estimates despite a decline. The company shifts focus to partnerships ...
Novavax reports large quarterly revenue declines, rethinks its strategic direction
Novavax (NVAX) reported a large fourth quarter sales decline Thursday — and said it no longer wants to be known simply as a ...
NVAX Earnings: Novavax Stock Jumps Despite Mixed Q4 Results
Novavax (NVAX) stock jumped today following the release of the vaccine maker’s Q4 2024 earnings report. That follows its diluted earnings per ...
COVID-19 vs. Vaccine Myocarditis: The Surprising Findings That Could Change Treatments
Scientists explored the differences in heart inflammation caused by COVID-19, anti-COVID-19 vaccines, and other viral ...
RFK Jr. promptly cancels vaccine advisory meeting, pulls flu shot campaign
Kennedy Jr. became the country's top health official, the Centers for Disease Control and Prevention has already pulled back ...
U.S. News & World Report4d
Novavax Sees Royalties, Reduced Expenses on COVID Vaccines From Sanofi Partnership
(Reuters) -Novavax on Thursday posted a narrower fourth-quarter loss and said it expects its licensing deal with French drugmaker Sanofi for COVID-19 vaccines to generate royalties, and reduce ...